Page 18 - Sera News Today

Get your own copy of this album at SwapaCD.com. If you're not yet a member, your first 2 cds and membership are free! All you have to do is post 10 cds you want to get rid of. Visit the site to find a huge selection of music!

Que Sera Sera is a magnificent show that pays homage to one of Hollywood’s greatest stars – Doris Day. Que Sera Sera is a show that celebrates the l...

In-depth analysis and perspectives on the issues, people and ideas that define Florida. Statewide coverage of top economic sectors and industries.

Cellist Giuseppina Ciarla will present a benefit concert at Sarasota’s Temple Sinai to benefit Emergency USA’s efforts in Ukraine.

With just ten days to go, the official trailer for Westworld season four has arrived, and it's every bit as trippy and unpredictable as we've come to expect as the humans and hosts fight to survive.

Sera Prognostics (NASDAQ:SERA – Get Rating) and Celcuity (NASDAQ:CELC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership. Analyst Ratings This is a summary of recent recommendations and […]

Sera Prognostics (NASDAQ:SERA – Get Rating) and Celcuity (NASDAQ:CELC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Insider & Institutional Ownership 63.2% of Sera Prognostics shares are […]

Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it contrast to its peers? We will compare Sera Prognostics to related companies based on the strength of its valuation, earnings, profitability, dividends, institutional ownership, risk and analyst recommendations. Insider and Institutional Ownership 63.2% of […]

Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 public companies in the “Medical laboratories” industry, but how does it contrast to its peers? We will compare Sera Prognostics to related companies based on the strength of its analyst recommendations, earnings, profitability, dividends, valuation, risk and institutional ownership. Valuation and Earnings This table compares […]

Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its peers? We will compare Sera Prognostics to related businesses based on the strength of its analyst recommendations, institutional ownership, valuation, risk, profitability, dividends and earnings. Profitability This table compares […]